Compile Data Set for Download or QSAR
Report error Found 172 Enz. Inhib. hit(s) with all data for entry = 11422
TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614140(US11744824, Example 153)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614139(US11744824, Example 152)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614019(US11744824, Example 32)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614144(US11744824, Example 157)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614143(US11744824, Example 156)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614142(US11744824, Example 155)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614141(US11744824, Example 154)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614148(US11744824, Example 161)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614028(US11744824, Example 41)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614027(US11744824, Example 40)
Affinity DataIC50: 100nMAssay Description:ADP-Glo assay kit was purchased from Promega. Magnesium chloride (MgCl2), bovine serum albumin (BSA), ethylene glycol-bis(β-aminoethyl ether)-N,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614146(US11744824, Example 159)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614027(US11744824, Example 40)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614145(US11744824, Example 158)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614031(US11744824, Example 44)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614149(US11744824, Example 162)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614121(US11744824, Example 134)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614002(US11744824, Example 15)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614132(US11744824, Example 145)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614129(US11744824, Example 142)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614047(US11744824, Example 60)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614051(US11744824, Example 64)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614050(US11744824, Example 63)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614056(US11744824, Example 69)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614055(US11744824, Example 68)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614054(US11744824, Example 67)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614061(US11744824, Example 74)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614060(US11744824, Example 73)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614038(US11744824, Example 51)
Affinity DataIC50: 100nMAssay Description:ADP-Glo assay kit was purchased from Promega. Magnesium chloride (MgCl2), bovine serum albumin (BSA), ethylene glycol-bis(β-aminoethyl ether)-N,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614038(US11744824, Example 51)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614037(US11744824, Example 50)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614046(US11744824, Example 59)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614045(US11744824, Example 58)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614044(US11744824, Example 57)
Affinity DataIC50: 100nMAssay Description:ADP-Glo assay kit was purchased from Promega. Magnesium chloride (MgCl2), bovine serum albumin (BSA), ethylene glycol-bis(β-aminoethyl ether)-N,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614044(US11744824, Example 57)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614077(US11744824, Example 90)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614084(US11744824, Example 97)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614082(US11744824, Example 95)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614081(US11744824, Example 94)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614088(US11744824, Example 101)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614087(US11744824, Example 100)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetTyrosine-protein kinase ABL1(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614091(US11744824, Example 104)
Affinity DataIC50: 100nMAssay Description:ADP-Glo assay kit was purchased from Promega. Magnesium chloride (MgCl2), bovine serum albumin (BSA), ethylene glycol-bis(β-aminoethyl ether)-N,...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614091(US11744824, Example 104)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614089(US11744824, Example 102)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614065(US11744824, Example 78)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614063(US11744824, Example 76)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614062(US11744824, Example 75)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614069(US11744824, Example 82)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614068(US11744824, Example 81)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614067(US11744824, Example 80)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

TargetReceptor-interacting serine/threonine-protein kinase 2(Human)
1St Biotherapeutics

US Patent
LigandPNGBDBM614066(US11744824, Example 79)
Affinity DataIC50: 100nMAssay Description:GST-tagged recombinant human RIP2 (25 ng) is incubated with 5 μL of compounds (0.5% DMSO), 5 μL of MBP (0.5 μg/μl) and 5 μL ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/6/2023
Entry Details
US Patent

Displayed 1 to 50 (of 172 total ) | Next | Last >>
Jump to: